Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06582784 · ClinicalTrials.gov registry record · NA
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
A NA study of Depression and Cancer, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 279
- Enrollment target
- 1
- Study location
NCT06582784 is a NA study of Depression and Cancer that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 279 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06582784, a NA study of Depression and Cancer, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 279 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate a mobile application (app) for depression treatment called "Moodivate" among cancer survivors. Moodivate was developed by our research team to assist with the treatment of depressed mood. Participants will be randomly assigned to either download the mobile app, "Moodivate", or not. Approximately 2/3 of participants enrolled will receive the mobile app and the remaining 1/3 will not. All participants will complete electronic questionnaire measures throughout the study period. Questionnaires will assess symptoms of depression, as well as your experiences using Moodivate and participating in this trial. Participation in this study will take about 12 weeks, beginning today. Participation in this study may help in the treatment of future cancer survivors. The greatest risks of this study include frustration, worsening of emotional distress, data breach, and/or loss of confidentiality. Alternative treatments include contacting your primary care provider or your oncology care team to discuss other available treatments for depressed mood.
Conditions Studied
Interventions
- BEHAVIORAL Behavioral Activation Therapy App
- BEHAVIORAL Treatment as Usual
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2024-10-28 |
| Est. Completion | 2029-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06582784
The ClinicalTrials.gov registry entry for NCT06582784 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 279 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (65% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Activation Therapy App is the first listed.
NCT06582784 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT06582784 about?
NCT06582784 is a clinical study titled "IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)". The purpose of this research study is to evaluate a mobile application (app) for depression treatment called "Moodivate" among cancer survivors. Moodivate was developed by our research team to assist with the treatment of depressed mood. Participants will be randomly assigned to either download the...
What is the current status of trial NCT06582784?
This trial is currently recruiting. It is a NA study. The enrollment target is 279 participants. The study started on 2024-10-28. Estimated completion is 2029-08-01.
What conditions does trial NCT06582784 study?
This clinical trial studies the following conditions: Depression, Cancer, Depressive Symptoms.
What interventions are being tested in trial NCT06582784?
The interventions under investigation include: Behavioral Activation Therapy App (BEHAVIORAL), Treatment as Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT06582784?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06582784 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.